newsfilter
← Latest News
GlobeNewswire·

Minerva Neurosciences to Participate in The Citizens Life Sciences Conference

  • Minerva Neurosciences, Inc. announced that Executive Chairman & CEO Remy Luthringer, PhD, will present at The Citizens Life Sciences Conference in Miami, FL.
  • The presentation is scheduled for Tuesday, March 10, 2026, at 9:35 AM ET.
  • The live webcast will be available at https://event.summitcast.com/view/BuMiPNPtyHKimMF6k4AFMd/SKrutqyvQVtnaKJDseE6uU.
  • A replay of the presentation will be accessible on the company's Investors & Media Events webpage for ninety days after the event.
  • Minerva Neurosciences is a clinical-stage biopharmaceutical company developing therapies for CNS disorders.
  • The company is initiating a confirmatory Phase 3 trial with roluperidone for the negative symptoms of schizophrenia.
  • Investor inquiries can be directed to CFO Frederick Ahlholm or Corey Davis, Ph.D., of LifeSci Advisors, LLC.